Cookie Policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read ourPrivacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

 

 

Terumo Announces European Medicines Agency Validates Marketing Authorization Application for a Biosimilar to Be Formulatedhttp://www.terumo-europe.com/en-emea/news/terumo-announces-european-medicines-agency-validates-marketing-authorization-application-for-a-biosimilar-to-be-formulatedTerumo Announces European Medicines Agency Validates Marketing Authorization Application for a Biosimilar to Be FormulatedTokyo, Japan22/05/2017 22:00:00
First patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientshttp://www.terumo-europe.com/en-emea/news/first-patient-enrolled-in-major-new-study-investigating-abbreviated-dapt-post-stent-in-high-bleeding-risk-patientsFirst patient enrolled in major new study investigating abbreviated DAPT post-stent in high bleeding risk patientsEmmen, The Netherlands03/04/2017 22:00:00
Terumo announces first commercial clinical case using QuiremSpheres®http://www.terumo-europe.com/en-emea/news/terumo-announces-first-commercial-clinical-case-using-quiremspheres®Terumo announces first commercial clinical case using QuiremSpheres®Leuven, Belgium27/03/2017 22:00:00

 

 

ESC 2017http://www.terumo-europe.com/en-emea/Events/ESC 2017.aspxESC 2017Spain25/08/2017 22:00:0030/08/2017 12:29:00Barcelonahttp://www.escardio.org/, http://www.escardio.org/
ESMO 2017http://www.terumo-europe.com/en-emea/Events/ESMO 2017.aspxESMO 2017Spain07/09/2017 22:00:0012/09/2017 12:31:00Madridhttp://www.esmo.org/Conferences/ESMO-2017-Congress, http://www.esmo.org/Conferences/ESMO-2017-Congress